Evaluation of pyrazoloacridine (PZA) [PD115934] in recurrent platinum sensitive ovarian cancer
Latest Information Update: 23 Dec 2005
At a glance
- Drugs PD 115934 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 23 Dec 2005 New trial record.